AU3096502A - Methods for inhibiting fibrosis - Google Patents

Methods for inhibiting fibrosis

Info

Publication number
AU3096502A
AU3096502A AU3096502A AU3096502A AU3096502A AU 3096502 A AU3096502 A AU 3096502A AU 3096502 A AU3096502 A AU 3096502A AU 3096502 A AU3096502 A AU 3096502A AU 3096502 A AU3096502 A AU 3096502A
Authority
AU
Australia
Prior art keywords
methods
inhibiting fibrosis
fibrosis
inhibiting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU3096502A
Inventor
Denise L Faustman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
General Hospital Corp
Original Assignee
General Hospital Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by General Hospital Corp filed Critical General Hospital Corp
Publication of AU3096502A publication Critical patent/AU3096502A/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/191—Tumor necrosis factors [TNF], e.g. lymphotoxin [LT], i.e. TNF-beta
AU3096502A 2000-12-15 2001-12-27 Methods for inhibiting fibrosis Pending AU3096502A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US25572800P 2000-12-15 2000-12-15
PCT/US2001/048811 WO2002047540A2 (en) 2000-12-15 2001-12-17 Methods for inhibiting fibrosis

Publications (1)

Publication Number Publication Date
AU3096502A true AU3096502A (en) 2002-06-24

Family

ID=22969613

Family Applications (1)

Application Number Title Priority Date Filing Date
AU3096502A Pending AU3096502A (en) 2000-12-15 2001-12-27 Methods for inhibiting fibrosis

Country Status (2)

Country Link
AU (1) AU3096502A (en)
WO (1) WO2002047540A2 (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6599719B2 (en) * 1994-11-07 2003-07-29 Human Genome Sciences, Inc. Nucleic acid molecules encoding tumor necrosis factor-gamma-alpha
US5955476A (en) * 1997-11-18 1999-09-21 Celgene Corporation Substituted 2-(2,6-dioxo-3-fluoropiperidin-3-yl)-isoindolines and method of reducing inflammatory cytokine levels
US6258833B1 (en) * 1999-12-23 2001-07-10 Icos Corporation Cyclic AMP-specific phosphodiesterase inhibitors

Also Published As

Publication number Publication date
WO2002047540A2 (en) 2002-06-20
WO2002047540A3 (en) 2009-06-11
AU2002230965A8 (en) 2009-07-30

Similar Documents

Publication Publication Date Title
GB0016459D0 (en) Method
AU7090201A (en) Method
GB0009353D0 (en) Method
GB0026390D0 (en) Method
GB0028108D0 (en) Method
GB0005867D0 (en) Method
GB0025132D0 (en) Method
GB0024884D0 (en) Method
GB0007873D0 (en) Method
GB0018039D0 (en) Method
AU2002230965A8 (en) Methods for inhibiting fibrosis
GB0022330D0 (en) Method
AU2002230965A1 (en) Methods for inhibiting fibrosis
GB0007872D0 (en) Method
GB0013260D0 (en) Method
GB0003837D0 (en) Method
GB0000659D0 (en) Method
GB0027063D0 (en) Method
GB0027661D0 (en) Method
GB0000591D0 (en) Method
GB0023068D0 (en) Method
GB0020800D0 (en) Method
GB0003440D0 (en) Method
GB0002271D0 (en) Detritiation method
GB0006034D0 (en) Method